Brief: Adaptive Biotechnologies Says New Data Showing Capability Of Immune Medicine Platform To Distinguish Sars-Cov-2 Infection,Vaccine Response,Detect Lyme Disease
02/10/2021 18:24
Oct 2 (Reuters) - Adaptive Biotechnologies Corp ADPT.O :
* NEW DATA SHOWING CAPABILITY OF IMMUNE MEDICINE PLATFORM TO
DISTINGUISH SARS-COV-2 INFECTION,VACCINE RESPONSE,DETECT LYME
DISEASE
Source text for Eikon: ID:nGNX6sHvmz
Further company coverage: ADPT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Adaptive Biotechnologies
See all newsBrief: Adaptive Biotechnologies Corp - Issues $345 Million In 0% Convertible Senior Notes Due 2031 - SEC Filing
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Jabil, BWX Technologies, Micron
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, CME
U.S. STOCKS ON THE MOVE-Intel, La-Z-Boy, AST SpaceMobile